BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34796992)

  • 61. Defective lysosomal storage in Fabry disease modifies mitochondrial structure, metabolism and turnover in renal epithelial cells.
    Schumann A; Schaller K; Belche V; Cybulla M; Grünert SC; Moers N; Sass JO; Kaech A; Hannibal L; Spiekerkoetter U
    J Inherit Metab Dis; 2021 Jul; 44(4):1039-1050. PubMed ID: 33661535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.
    Ferreira S; Ortiz A; Germain DP; Viana-Baptista M; Caldeira-Gomes A; Camprecios M; Fenollar-Cortés M; Gallegos-Villalobos Á; Garcia D; García-Robles JA; Egido J; Gutiérrez-Rivas E; Herrero JA; Mas S; Oancea R; Péres P; Salazar-Martín LM; Solera-Garcia J; Alves H; Garman SC; Oliveira JP
    Mol Genet Metab; 2015 Feb; 114(2):248-58. PubMed ID: 25468652
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Application of Genetic Testing in Unveiling the Diagnosis of Fabry Disease in a Patient with Hypertrophic Cardiomyopathy.
    Gedela M; Sharma R; DeBerg K; Stanton C
    S D Med; 2021 Apr; 74(4):150-152. PubMed ID: 34432960
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fabry disease in children and the effects of enzyme replacement treatment.
    Pintos-Morell G; Beck M
    Eur J Pediatr; 2009 Nov; 168(11):1355-63. PubMed ID: 19242721
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience.
    Gragnaniello V; Burlina AP; Polo G; Giuliani A; Salviati L; Duro G; Cazzorla C; Rubert L; Maines E; Germain DP; Burlina AB
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34199132
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
    Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
    Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fabry disease - Vascular manifestations.
    Karetova D; Bultas J; Dostalova G; Palecek T; Kovarnik T; Golan L; Linhart A
    Vasa; 2010 May; 39(2):123-31. PubMed ID: 20464667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fabry disease: treatment and diagnosis.
    Rozenfeld PA
    IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study.
    Oder D; Liu D; Üçeyler N; Sommer C; Hu K; Salinger T; Müntze J; Petritsch B; Ertl G; Wanner C; Nordbeck P; Weidemann F
    Medicine (Baltimore); 2018 May; 97(21):e10669. PubMed ID: 29794742
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice.
    Lakomá J; Rimondini R; Donadio V; Liguori R; Caprini M
    PLoS One; 2014; 9(10):e108641. PubMed ID: 25337704
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease.
    Pastores GM; Boyd E; Crandall K; Whelan A; Piersall L; Barnett N
    Nephrol Dial Transplant; 2007 Jul; 22(7):1920-5. PubMed ID: 17395657
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes.
    Adalsteinsdottir B; Palsson R; Desnick RJ; Gardarsdottir M; Teekakirikul P; Maron M; Appelbaum E; Neisius U; Maron BJ; Burke MA; Chen B; Pagant S; Madsen CV; Danielsen R; Arngrimsson R; Feldt-Rasmussen U; Seidman JG; Seidman CE; Gunnarsson GT
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28798024
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fabry disease.
    Toyooka K
    Handb Clin Neurol; 2013; 115():629-42. PubMed ID: 23931807
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fabry disease: what the cardiologist should consider in non-cardiac screening, diagnosis, and management-narrative review.
    Regenbogen C; Braunisch MC; Schmaderer C; Heemann U
    Cardiovasc Diagn Ther; 2021 Apr; 11(2):661-671. PubMed ID: 33968643
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Generalized anhidrosis associated with Fabry's disease.
    Kang WH; Chun SI; Lee S
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 2):883-7. PubMed ID: 3119682
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial.
    Ramaswami U; Bichet DG; Clarke LA; Dostalova G; Fainboim A; Fellgiebel A; Forcelini CM; An Haack K; Hopkin RJ; Mauer M; Najafian B; Scott CR; Shankar SP; Thurberg BL; Tøndel C; Tylki-Szymanska A; Bénichou B; Wijburg FA
    Mol Genet Metab; 2019 May; 127(1):86-94. PubMed ID: 30987917
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pathophysiological aspects of brain structural disturbances in patients with Fabry disease: literature review].
    Nill M; Müller MJ; Beck M; Stoeter P; Fellgiebel A
    Fortschr Neurol Psychiatr; 2006 Dec; 74(12):687-95. PubMed ID: 17167727
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dermatologic manifestations and neuropathic symptoms in women with Fabry disease.
    Melpignano A; Mandurino-Mirizzi A; Besagni F; Leri A
    Acta Biomed; 2014 May; 85(1):81-4. PubMed ID: 24897976
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Imbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells.
    Tseng WL; Chou SJ; Chiang HC; Wang ML; Chien CS; Chen KH; Leu HB; Wang CY; Chang YL; Liu YY; Jong YJ; Lin SZ; Chiou SH; Lin SJ; Yu WC
    Cell Transplant; 2017 Mar; 26(3):513-527. PubMed ID: 27938475
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fabry Disease on Peritoneal Dialysis with Cardiac Involvement.
    Koga-Kobori S; Sawa N; Kido R; Sekine A; Mizuno H; Yamanouchi M; Hayami N; Suwabe T; Hoshino J; Kinowaki K; Ohashi K; Fujii T; Ubara Y
    Intern Med; 2021 May; 60(10):1561-1565. PubMed ID: 33361676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.